210 related articles for article (PubMed ID: 15890955)
1. Inhibition of the herpes simplex virus type 1 DNA polymerase induces hyperphosphorylation of replication protein A and its accumulation at S-phase-specific sites of DNA damage during infection.
Wilkinson DE; Weller SK
J Virol; 2005 Jun; 79(11):7162-71. PubMed ID: 15890955
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of polymerase to herpes simplex virus type 1 replication foci in cells expressing mutant primase (UL52) proteins.
Carrington-Lawrence SD; Weller SK
J Virol; 2003 Apr; 77(7):4237-47. PubMed ID: 12634381
[TBL] [Abstract][Full Text] [Related]
3. Enhanced phosphorylation of transcription factor sp1 in response to herpes simplex virus type 1 infection is dependent on the ataxia telangiectasia-mutated protein.
Iwahori S; Shirata N; Kawaguchi Y; Weller SK; Sato Y; Kudoh A; Nakayama S; Isomura H; Tsurumi T
J Virol; 2007 Sep; 81(18):9653-64. PubMed ID: 17609267
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of cellular recombination and repair proteins to sites of herpes simplex virus type 1 DNA replication is dependent on the composition of viral proteins within prereplicative sites and correlates with the induction of the DNA damage response.
Wilkinson DE; Weller SK
J Virol; 2004 May; 78(9):4783-96. PubMed ID: 15078960
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
[TBL] [Abstract][Full Text] [Related]
6. H2AX phosphorylation and DNA damage kinase activity are dispensable for herpes simplex virus replication.
Botting C; Lu X; Triezenberg SJ
Virol J; 2016 Jan; 13():15. PubMed ID: 26817608
[TBL] [Abstract][Full Text] [Related]
7. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus type 1 DNA polymerase requires the mammalian chaperone hsp90 for proper localization to the nucleus.
Burch AD; Weller SK
J Virol; 2005 Aug; 79(16):10740-9. PubMed ID: 16051866
[TBL] [Abstract][Full Text] [Related]
9. Assembly of complete, functionally active herpes simplex virus DNA replication compartments and recruitment of associated viral and cellular proteins in transient cotransfection assays.
Zhong L; Hayward GS
J Virol; 1997 Apr; 71(4):3146-60. PubMed ID: 9060678
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus type I disrupts the ATR-dependent DNA-damage response during lytic infection.
Wilkinson DE; Weller SK
J Cell Sci; 2006 Jul; 119(Pt 13):2695-703. PubMed ID: 16757521
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus induces extensive modification and dynamic relocalisation of the nuclear mitotic apparatus (NuMA) protein in interphase cells.
Yamauchi Y; Kiriyama K; Kimura H; Nishiyama Y
J Cell Sci; 2008 Jun; 121(Pt 12):2087-96. PubMed ID: 18505791
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus type 1 prereplicative sites are a heterogeneous population: only a subset are likely to be precursors to replication compartments.
Lukonis CJ; Burkham J; Weller SK
J Virol; 1997 Jun; 71(6):4771-81. PubMed ID: 9151871
[TBL] [Abstract][Full Text] [Related]
13. Roles of the Phosphorylation of Herpes Simplex Virus 1 UL51 at a Specific Site in Viral Replication and Pathogenicity.
Kato A; Oda S; Watanabe M; Oyama M; Kozuka-Hata H; Koyanagi N; Maruzuru Y; Arii J; Kawaguchi Y
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976672
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus type 1 regulatory protein ICP0 does not protect cyclins D1 and D3 from degradation during infection.
Everett RD
J Virol; 2004 Sep; 78(18):9599-604. PubMed ID: 15331692
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of the herpes simplex virus type 1 origin binding protein.
Isler JA; Schaffer PA
J Virol; 2001 Jan; 75(2):628-37. PubMed ID: 11134276
[TBL] [Abstract][Full Text] [Related]
16. A mutation in the human herpes simplex virus type 1 UL52 zinc finger motif results in defective primase activity but can recruit viral polymerase and support viral replication efficiently.
Chen Y; Livingston CM; Carrington-Lawrence SD; Bai P; Weller SK
J Virol; 2007 Aug; 81(16):8742-51. PubMed ID: 17553899
[TBL] [Abstract][Full Text] [Related]
17. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.
Yajima M; Yamada H; Takemoto M; Daikoku T; Yoshida Y; Long T; Okuda T; Shiraki K
Antiviral Res; 2017 Mar; 139():95-101. PubMed ID: 28027917
[TBL] [Abstract][Full Text] [Related]
18. Characterization of nuclear structures in cells infected with herpes simplex virus type 1 in the absence of viral DNA replication.
Lukonis CJ; Weller SK
J Virol; 1996 Mar; 70(3):1751-8. PubMed ID: 8627697
[TBL] [Abstract][Full Text] [Related]
19. ATR and ATRIP are recruited to herpes simplex virus type 1 replication compartments even though ATR signaling is disabled.
Mohni KN; Livingston CM; Cortez D; Weller SK
J Virol; 2010 Dec; 84(23):12152-64. PubMed ID: 20861269
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of herpes simplex virus type 1 replication by adeno-associated virus rep proteins depends on their combined DNA-binding and ATPase/helicase activities.
Glauser DL; Seyffert M; Strasser R; Franchini M; Laimbacher AS; Dresch C; de Oliveira AP; Vogel R; Büning H; Salvetti A; Ackermann M; Fraefel C
J Virol; 2010 Apr; 84(8):3808-24. PubMed ID: 20106923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
